말초 혈관 기기 시장 : 유형별(혈관 성형술용 풍선, 스텐트, 카테터(가이드 카테터, IVUS 카테터), 하대정맥 필터, 아테렉토미, 혈전 제거술, 혈류 제어(색전 방지, 폐색)) 및 지역별 예측(-2036년)

According to the research report titled, 'Peripheral Vascular Devices Market by Type [Angioplasty Balloon, Stents, Catheters (Guiding, IVUS), IVC Filter, Atherectomy, Thrombectomy, Hemodynamic Flow Alteration (Embolic Protection, Occlusion)] and Geography - Global Forecast to 2036,' the global peripheral vascular devices market is expected to reach approximately USD 21.6 billion by 2036 from USD 10.49 billion in 2026, at a CAGR of 7.5% during the forecast period (2026-2036). The report provides an in-depth analysis of the global peripheral vascular devices market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036.

Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The major factors driving the growth of the peripheral vascular devices market include rising prevalence of peripheral artery disease (PAD), aging global population, and increasing adoption of minimally invasive endovascular procedures. Additionally, technological advancements in drug-eluting stents and balloons, development of bioresorbable scaffolds, focus on treating complex lesions and below-the-knee disease, and growing awareness about early diagnosis and treatment are expected to create significant growth opportunities for players operating in the peripheral vascular devices market.

Market Segmentation

The peripheral vascular devices market is segmented by type (angioplasty balloon, stents, catheters, IVC filter, atherectomy, thrombectomy, hemodynamic flow alteration) and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Type

By type, the angioplasty stents segment is expected to account for the largest share of the peripheral vascular devices market in 2026. Stents are the most widely used devices for treating arterial blockages, providing a mechanical scaffold to keep the vessel open and restore blood flow. The development of drug-eluting stents (DES), which release medication to prevent the recurrence of blockages, has further solidified their position as the standard of care. Drug-eluting balloons are projected to grow at the fastest CAGR, driven by their ability to deliver anti-proliferative drugs directly to the vessel wall without requiring permanent stent implants. Other segments include angioplasty balloons, catheters (guiding and IVUS), IVC filters, atherectomy devices, thrombectomy systems, and hemodynamic flow alteration devices.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America is expected to dominate the global peripheral vascular devices market with the largest market share in 2026, attributed to high prevalence of peripheral vascular diseases, well-established healthcare system with high rates of diagnosis and treatment, and favorable reimbursement policies for endovascular procedures. Asia-Pacific is projected to witness the fastest growth during the forecast period, driven by large and aging population, rising prevalence of risk factors like diabetes and hypertension, and increasing healthcare investments in countries like China and India.

Key Players

The key players operating in the global peripheral vascular devices market are Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Terumo Corporation (Japan), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (BD) (U.S.), Cardinal Health, Inc. (U.S.), Cook Group (U.S.), Koninklijke Philips N.V. (Netherlands), and various other regional and emerging manufacturers, among others.

Key Questions Answered in the Report-

• What is the current revenue generated by the peripheral vascular devices market globally?
• At what rate is the global peripheral vascular devices market demand projected to grow for the next 7-10 years?
• What are the historical market sizes and growth rates of the global peripheral vascular devices market?
• What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
• Which segments in terms of type are expected to create major traction for the service providers in this market?
• What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global peripheral vascular devices market?
• Who are the major players in the global peripheral vascular devices market? What are their specific service offerings in this market?
• What are the recent strategic developments in the global peripheral vascular devices market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Peripheral Vascular Devices Market Assessment -- by Type

• Angioplasty Balloon
• Stents
• Catheters (Guiding, IVUS)
• IVC Filter
• Atherectomy
• Thrombectomy
• Hemodynamic Flow Alteration (Embolic Protection, Occlusion)

Peripheral Vascular Devices Market Assessment -- by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Southeast Asia
• Rest of Asia-Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency and Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Process
• 2.2. Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research
• 2.3. Market Assessment
  • 2.3.1. Market Size Estimation
  • 2.3.2. Bottom-Up Approach
  • 2.3.3. Top-Down Approach
  • 2.3.4. Growth Forecast
• 2.4. Assumptions for the Study

3. Executive Summary

• 3.1. Overview
• 3.2. Market Analysis, by Type
• 3.3. Market Analysis, by Geography
• 3.4. Competitive Analysis

4. Market Insights

• 4.1. Market Overview
• 4.2. Drivers
  • 4.2.1. Rising Geriatric Population and PAD Prevalence
  • 4.2.2. Increasing Adoption of Minimally Invasive Procedures
• 4.3. Restraints
  • 4.3.1. High Cost of Advanced Devices
  • 4.3.2. Product Failures and Recalls
• 4.4. Opportunities
  • 4.4.1. Emerging Markets and Untapped Patient Populations
  • 4.4.2. Technological Innovations
• 4.5. Trends
  • 4.5.1. Bioresorbable Scaffolds and Drug-Coated Balloons
  • 4.5.2. Focus on Complex Lesions and BTK Disease

5. Global Peripheral Vascular Devices Market, by Type

• 5.1. Introduction
• 5.2. Angioplasty Balloons
  • 5.2.1. Old/Normal Balloons
  • 5.2.2. Drug-Eluting Balloons (DEB)
• 5.3. Angioplasty Stents
  • 5.3.1. Drug-Eluting Stents (DES)
  • 5.3.2. Bare Metal Stents
    • 5.3.2.1. Balloon-Expandable Stents
    • 5.3.2.2. Self-Expandable Stents
• 5.4. Catheters
  • 5.4.1. Angiography Catheters
  • 5.4.2. Guiding Catheters
  • 5.4.3. IVUS/OCT Catheters
• 5.5. Endovascular Aneurysm Repair (EVAR) Stent Grafts
  • 5.5.1. Abdominal EVAR Grafts
  • 5.5.2. Thoracic EVAR Grafts
• 5.6. Inferior Vena Cava (IVC) Filters
  • 5.6.1. Retrievable Filters
  • 5.6.2. Permanent Filters
• 5.7. Plaque Modification Devices
  • 5.7.1. Atherectomy Devices
  • 5.7.2. Thrombectomy Devices
• 5.8. Hemodynamic Flow Alteration Devices
  • 5.8.1. Embolic Protection Devices
  • 5.8.2. Chronic Total Occlusion (CTO) Devices
• 5.9. Other Devices
  • 5.9.1. Vascular Closure Devices
  • 5.9.2. Synthetic Surgical Grafts

6. Global Peripheral Vascular Devices Market, by Geography

• 6.1. Introduction
• 6.2. North America
  • 6.2.1. U.S.
  • 6.2.2. Canada
• 6.3. Europe
  • 6.3.1. Germany
  • 6.3.2. France
  • 6.3.3. U.K.
  • 6.3.4. Italy
  • 6.3.5. Spain
  • 6.3.6. Rest of Europe
• 6.4. Asia-Pacific
  • 6.4.1. Japan
  • 6.4.2. China
  • 6.4.3. India
  • 6.4.4. Rest of Asia-Pacific
• 6.5. Latin America
• 6.6. Middle East & Africa

7. Competitive Landscape

• 7.1. Introduction
• 7.2. Market Structure Analysis (Tiered Vendor Landscape)
• 7.3. Key Growth Strategies
  • 7.3.1. Mergers & Acquisitions
  • 7.3.2. Partnerships & Collaborations
  • 7.3.3. Product Launches & Upgrades
• 7.4. Competitive Dashboard
• 7.5. Vendor Market Positioning
• 7.6. Market Share Analysis
• 7.7. Strategic Recommendations

8. Company Profiles

• 8.1. Medtronic plc
• 8.2. Boston Scientific Corporation
• 8.3. Abbott Laboratories
• 8.4. Terumo Corporation
• 8.5. B. Braun Melsungen AG
• 8.6. Becton, Dickinson and Company
• 8.7. Cardinal Health, Inc.
• 8.8. Cook Group
• 8.9. Koninklijke Philips N.V.
• 8.10. BIOTRONIK SE & Co. KG
• 8.11. AngioDynamics, Inc.
• 8.12. Teleflex Incorporated
• 8.13. OrbusNeich Medical Group Holdings Limited
• 8.14. Merit Medical Systems, Inc.
• 8.15. MicroPort Scientific Corporation
• 8.16. Penumbra, Inc.
• 8.17. Cordis (a Cardinal Health Company)
• 8.18. Lake Region Medical Holdings, Inc.
• 8.19. Others

9. Appendix

• 9.1. Questionnaire
• 9.2. Available Customization